Machine Learning Using Multiparametric Magnetic Resonance Imaging Radiomic Feature Analysis to Predict Ki-67 in World Health Organization Grade I Meningiomas.
暂无分享,去创建一个
C. Davatzikos | A. Sharan | A. Dicker | A. Fathi Kazerooni | D. Andrews | A. Flanders | K. Judy | M. Baldassari | O. Khanna | M. Karsy | W. Shi | C. Sako | T. Alexander | C. Farrell | James J. Evans | B. Greenberger | Jose Garcia | Jose A Garcia | Anahita Fathi Kazerooni | Michael P. Baldassari
[1] D. Andrews,et al. Resected WHO grade I meningioma and predictors of local control , 2021, Journal of Neuro-Oncology.
[2] J. Barnholtz-Sloan,et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017. , 2020, Neuro-oncology.
[3] Kaith K. Almefty,et al. Prognostic value of the Simpson grading scale in modern meningioma surgery: Barrow Neurological Institute experience. , 2020, Journal of neurosurgery.
[4] M. Berger,et al. Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma , 2020, Nature Communications.
[5] Jacob S. Young,et al. WHO Grade I Meningioma Recurrence: Identifying High Risk Patients Using Histopathological Features and the MIB-1 Index , 2020, Frontiers in Oncology.
[6] W. Stummer,et al. Risk of tumor recurrence in intracranial meningiomas: comparative analyses of the predictive value of the postoperative tumor volume and the Simpson classification. , 2020, Journal of neurosurgery.
[7] J. Bartek,et al. The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracranial Meningioma. , 2020, Neurosurgery.
[8] Si-ying Song,et al. The prognostic role of Ki-67/MIB-1 in meningioma , 2020, Medicine.
[9] Gabriel N Friedman,et al. Predicting Discharge Disposition Following Meningioma Resection Using a Multiinstitutional Natural Language Processing Model , 2020, Journal of Neurological Surgery Part B: Skull Base.
[10] S. Bakas,et al. Imaging signatures of glioblastoma molecular characteristics: A radiogenomics review , 2020, Journal of magnetic resonance imaging : JMRI.
[11] Sanjay Aneja,et al. Applications of artificial intelligence in neuro-oncology. , 2019, Current opinion in neurology.
[12] Christos Davatzikos,et al. Precision diagnostics based on machine learning-derived imaging signatures. , 2019, Magnetic resonance imaging.
[13] Christos Davatzikos,et al. The Cancer Imaging Phenomics Toolkit (CaPTk): Technical Overview , 2019, BrainLes@MICCAI.
[14] D. Dong,et al. A deep learning radiomics model for preoperative grading in meningioma. , 2019, European journal of radiology.
[15] Xuexi Zhang,et al. Differentiation Researches on the Meningioma Subtypes by Radiomics from Contrast-Enhanced Magnetic Resonance Imaging: A Preliminary Study. , 2019, World neurosurgery.
[16] Efstathios D. Gennatas,et al. Integrated models incorporating radiologic and radiomic features predict meningioma grade, local failure, and overall survival , 2019, Neuro-oncology advances.
[17] A. Hale,et al. Machine learning analyses can differentiate meningioma grade by features on magnetic resonance imaging. , 2018, Neurosurgical focus.
[18] David L Rimm,et al. Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study , 2018, Laboratory Investigation.
[19] Christos Davatzikos,et al. In vivo evaluation of EGFRvIII mutation in primary glioblastoma patients via complex multiparametric MRI signature , 2018, Neuro-oncology.
[20] A. Fathi Kazerooni,et al. ADC‐derived spatial features can accurately classify adnexal lesions , 2018, Journal of magnetic resonance imaging : JMRI.
[21] M. Karsy,et al. Microvascularization of Grade I meningiomas: effect on tumor volume, blood loss, and patient outcome. , 2017, Journal of neurosurgery.
[22] Christos Davatzikos,et al. Cancer imaging phenomics toolkit: quantitative imaging analytics for precision diagnostics and predictive modeling of clinical outcome , 2018, Journal of medical imaging.
[23] Raymond Y Huang,et al. Radiographic prediction of meningioma grade by semantic and radiomic features , 2017, PloS one.
[24] P. Lambin,et al. Radiomics: the bridge between medical imaging and personalized medicine , 2017, Nature Reviews Clinical Oncology.
[25] A. Berlin,et al. Prognostic role of Ki-67 score in localized prostate cancer: A systematic review and meta-analysis. , 2017, Urologic oncology.
[26] S. Torp,et al. Significance of the Extent of Resection in Modern Neurosurgical Practice of World Health Organization Grade I Meningiomas. , 2017, World neurosurgery.
[27] Prateek Prasanna,et al. Co-occurrence of Local Anisotropic Gradient Orientations (CoLlAGe): A new radiomics descriptor , 2016, Scientific Reports.
[28] G. Reifenberger,et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.
[29] Luke Macyszyn,et al. Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques. , 2016, Neuro-oncology.
[30] A. Niemierko,et al. Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes. , 2016, Journal of neurosurgery.
[31] Eun Hee Lee,et al. Results of immunohistochemical staining for cell cycle regulators predict the recurrence of atypical meningiomas. , 2014, Journal of neurosurgery.
[32] B. Yin,et al. Correlating apparent diffusion coefficients with histopathologic findings on meningiomas. , 2012, European journal of radiology.
[33] K. Kawai,et al. Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas. , 2012, Journal of neurosurgery.
[34] W. Vandertop,et al. Impaired survival and long-term neurological problems in benign meningioma. , 2012, Neuro-oncology.
[35] S. Uppin,et al. Meningiomas: correlation of Ki67 with histological grade. , 2011, Neurology India.
[36] O. Kim,et al. Peritumoral brain edema in meningiomas : correlation of radiologic and pathologic features. , 2011, Journal of Korean Neurosurgical Society.
[37] A. Sari,et al. MIB-1 counting methods in meningiomas and agreement among pathologists. , 2008, Analytical and quantitative cytology and histology.
[38] Alberto Orfao,et al. Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone. , 2007, Neuro-oncology.
[39] J. Lafitte,et al. Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis , 2004, British Journal of Cancer.
[40] M. Samii,et al. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases , 2004, Acta Neurochirurgica.
[41] J. Arends,et al. MIB-1 labelling index is an independent prognostic marker in primary breast cancer. , 1998, British Journal of Cancer.
[42] M. Jimbo,et al. MIB‐1 staining index and peritumoral brain edema of meningiomas , 1996, Cancer.